Mediwound Ltd (NASDAQ:MDWD)
| 9.51 Delayed Data As of 2:20pm ET |  -0.15 / -1.55%Today’s Change | 8.05 Today|||52-Week Range 15.72 | -29.50% Year-to-Date |
Latest MDWD News | Press Releases
| MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates May 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.66 |
| Today’s open | 9.48 |
| Day’s range | 9.48 - 9.51 |
| Volume | 119 |
| Average volume (3 months) | 24,953 |
| Market cap | $85.0M |
Data as of 2:20pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -12.88% |
| Earnings growth (this year) | +57.38% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +11.50% |
| P/E ratio | NM |
| Price/Sales | 2.54 |
| Price/Book | 5.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ORTXOrchard Therapeutics... | -0.10 | -2.01% |
| SPROSpero Therapeutics I... | -0.01 | -0.56% |
| SCTLSocietal CDMO Inc | +0.00 | +0.01% |
| SCYXSCYNEXIS Inc | +0.16 | +6.18% |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $26.5M |
| Annual profit (last year) | -$19.6M |
| Net profit margin | -73.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Yavne, Hamerkaz |
Forecasts
